← back to search

Benjamin J. Fowler

University of Wisconsin–Madison · US
Area of research
Ophthalmology · Molecular Biology
Research interest
Research interests include Retinal Diseases and Treatments, Ocular Diseases and Behçet’s Syndrome, Inflammasome and immune disorders, and interferon and immune responses.
h-index
23
citations
4,163
works
74
NIH funding
primary concept
email

Recent publications

Cytoplasmic synthesis of endogenous <i>Alu</i> complementary DNA via reverse transcription and implications in age-related macular degeneration
Proceedings of the National Academy of Sciences 2021cited by 63position: middledoi
<i>Alu</i> complementary DNA is enriched in atrophic macular degeneration and triggers retinal pigmented epithelium toxicity via cytosolic innate immunity
Science Advances 2021cited by 51position: middledoi
Postoperative Endophthalmitis Caused by &lt;b&gt;&lt;i&gt;Cutibacterium&lt;/i&gt;&lt;/b&gt; (Formerly &lt;b&gt;&lt;i&gt;Propionibacterium&lt;/i&gt;&lt;/b&gt;) Acnes: Case Series and Review
Case Reports in Ophthalmology 2021cited by 22position: firstdoi
Latent Sensitization in a Mouse Model of Ocular Neuropathic Pain
Translational Vision Science & Technology 2019cited by 27position: middledoi
cGAS drives noncanonical-inflammasome activation in age-related macular degeneration
Nature Medicine 2017cited by 292position: middledoi
Human IgG1 antibodies suppress angiogenesis in a target-independent manner
Signal Transduction and Targeted Therapy 2016cited by 37position: middledoi
Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity
Science 2014cited by 228position: firstdoi
DICER1/ <i>Alu</i> RNA dysmetabolism induces Caspase-8–mediated cell death in age-related macular degeneration
Proceedings of the National Academy of Sciences 2014cited by 91position: middledoi
IL-18 is not therapeutic for neovascular age-related macular degeneration
Nature Medicine 2014cited by 42position: middledoi
DICER1 Loss and Alu RNA Induce Age-Related Macular Degeneration via the NLRP3 Inflammasome and MyD88
Cell 2012cited by 592position: middledoi
ERK1/2 activation is a therapeutic target in age-related macular degeneration
Proceedings of the National Academy of Sciences 2012cited by 101position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yoshio Hirano · University of Kentucky4 papers (2012–2014)Jayakrishna Ambati · University of Kentucky4 papers (2012–2014)Bradley D. Gelfand · University of Kentucky4 papers (2012–2014)David R. Hinton · University of Southern California4 papers (2012–2014)Valeria Tarallo · University of Kentucky4 papers (2012–2014)Ana Bastos-Carvalho · University of Kentucky3 papers (2014–2014)Reo Yasuma · University of Kentucky3 papers (2014–2014)Balamurali K. Ambati · University of Oregon3 papers (2012–2014)Sasha Bogdanovich · University of Pennsylvania3 papers (2012–2014)Tetsuhiro Yasuma · University of Kentucky3 papers (2014–2014)Takeshi Mizutani · University of Kentucky3 papers (2014–2014)Nagaraj Kerur · University of Kentucky3 papers (2014–2014)William W. Hauswirth · University of Florida2 papers (2012–2014)Young‐Hee Kim · Columbia University2 papers (2014–2014)Younghee Kim · University of Kentucky2 papers (2012–2014)Shengjian Li · University of Kentucky2 papers (2014–2014)Charles B. Wright · University of Kentucky2 papers (2014–2014)Hiroki Kaneko · University of Kentucky2 papers (2014–2014)Sami Dridi · University of Kentucky1 papers (2012–2012)Darlene Miller · University of Miami1 papers (2021–2021)